Home › Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs
 

Keywords :   


Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs

2016-02-06 15:04:08| Biotech - Topix.net

's stock had its "neutral" rating reissued by research analysts at Goldman Sachs in a note issued to investors on Saturday, AnalystRatings.Net reports. They currently have a $56.00 target price on the stock, down from their previous target price of $60.00.

Tags: rating neutral goldman sachs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »